Insulet (PODD) Tops Q2 EPS by 9c, Lifts Revenue Guidance

Go back to Insulet (PODD) Tops Q2 EPS by 9c, Lifts Revenue Guidance

Wedbush Raises Price Target on Insulet (PODD) to $48 Following 2Q Beat

August 4, 2016 10:01 AM EDT

Wedbush reiterated an Outperform rating on Insulet Corporation (NASDAQ: PODD), and raised the price target to $48.00 (from $44.00), following the company's 2Q earnings report. Revenues of $87 million were $4 million ahead of consensus. EPS of ($0.07) was 10c better than consensus.

Analyst Tao Levy commented,... More

Leerink Partners Raises Price Target on Insulet (PODD) to $50; Reiterates Outperform

August 4, 2016 7:24 AM EDT

Leerink Partners reiterated an Outperform rating on Insulet Corporation (NASDAQ: PODD), and raised the price target to $50.00 (from $40.00), following the company's 2Q earnings report.

Analyst Danielle Antalffy commented, "Another strong quarter of outperformance supports our recent view that PODD is... More

Insulet Corporation (PODD) PT Raised to $46 at Piper Jaffray

August 4, 2016 6:52 AM EDT

Piper Jaffray analyst Brooks West reiterated an Overweight rating and raised his price target on Insulet Corporation (NASDAQ: PODD) to $46.00 (from $41.00) following strong Q2 results.

West commented, "Insulet posted 2Q16 revenues of $87.3M (+44% proforma), 5%+ above the consensus estimate of $83.0M, primarily on strength in... More